Frankel, A E <br/><br/>
Therapy of patients with T-cell lymphomas and leukemias using an anti-CD7 monoclonal antibody-ricin A chain immunotoxin.  [electronic resource] 

 -  Leukemia & lymphoma  Jul 1997 
 - 287-98 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1042-8194 
<br/><br/><label>Standard No.: </label>10.3109/10428199709051778  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Animals<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Neoplasm--biosynthesis<br/>Antigens, CD7--immunology<br/>Child<br/>Child, Preschool<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Endothelium, Vascular--metabolism<br/>Female<br/>Fibronectins--blood<br/>Humans<br/>Immunotoxins--adverse effects<br/>Infusions, Intravenous<br/>Leukemia, T-Cell--drug therapy<br/>Lymphoma, T-Cell--drug therapy<br/>Male<br/>Mice<br/>Middle Aged<br/>Ricin--adverse effects